| [1] |
Parikh AO, Conger JR, Li J, et al. A review of current uses of amniotic membrane transplantation in ophthalmic plastic and reconstructive surgery[J]. Ophthalmic Plast Reconstr Surg, 2024, 40(2): 134－149.
|
| [2] |
Kalirajan C, Dukle A, Nathanael AJ, et al. A Critical review on polymeric biomaterials for biomedical applications[J]. Polymers (Basel), 2021, 13(17): 3015.
|
| [3] |
Amador C, Shah R, Ghiam S, et al. Gene therapy in the anterior eye segment[J]. Curr Gene Ther. 2022, 22(2): 104－131.
|
| [4] |
Tonti E, Manco GA, Spadea L, et al. Focus on limbal stem cell deficiency and limbal cell transplantation[J]. World J Transplant, 2023, 13(6): 321－330.
|
| [5] |
Kate A, Basu S. A review of the diagnosis and treatment of limbal stem cell deficiency[J]. Front Med, 2022, 9: 836009.
|
| [6] |
Atalay E, Altuğ B, Çalᶊkan ME, et al. Animal models for limbal stem cell deficiency: a critical narrative literature review [J]. Ophthalmol Ther, 2024, 13(3): 671－696.
|
| [7] |
Ganger A, Singh A, Kalaivani M, et al. Outcomes of surgical interventions for the treatment of limbal stem cell deficiency[J]. Indian J Med Res, 2021, 154(1): 51－61.
|
| [8] |
Jurkunas U, Johns L, Armant M. Cultivated autologous limbal epithelial cell transplantation: new frontier in the treatment of limbal stem cell deficiency[J]. Am J Ophthalmol, 2022, 239: 244－268.
|
| [9] |
Cabral JV, Jackson CJ, Utheim TP, et al. Ex vivo cultivated oral mucosal epithelial cell transplantation for limbal stem cell deficiency: a review[J]. Stem Cell Res Ther, 2020, 11(1): 301.
|
| [10] |
Figueiredo FC, Glanville JM, Arber M, et al. A systematic review of cellular therapies for the treatment of limbal stem cell deficiency affecting one or both eyes[J]. Ocul Surf, 2021, 20: 48－61.
|
| [11] |
da－Mata－Martins－TM, da－Silva－Cunha P, Rodrigues MA, et al. Epithelial basement membrane of human decellularized cornea as a suitable substrate for differentiation of embryonic stem cells into corneal epithelial－like cells[J]. Mater Sci Eng C Mater Biol Appl, 2020, 116: 111215.
|
| [12] |
He J, Ou S, Ren J, et al. Tissue engineered corneal epithelium derived from clinical－grade human embryonic stem cells[J]. Ocul Surf. 2020, 18(4): 672－680.
|
| [13] |
寿天.人类胚胎干细胞法律规制的路径研究[J]. 医学与法学，2024，16(2)：81－85.
|
| [14] |
Calonge M, Nieto－Miguel T, de－la－Mata A, et al. Goals and challenges of stem cell－based therapy for corneal blindness due to limbal deficiency[J]. Pharmaceutics, 2021, 13(9): 1483.
|
| [15] |
Masood F, Chang JH, Akbar A, et al. Therapeutic strategies for restoring perturbed corneal epithelial homeostasis in limbal stem cell deficiency: current trends and future directions[J]. Cells, 2022, 11(20): 3247.
|
| [16] |
Zhang N, Luo X, Zhang S, et al. Subconjunctival injection of tumor necrosis factor－α pre－stimulated bone marrow－derived mesenchymal stem cells enhances anti－inflammation and anti－fibrosis in ocular alkali burns[J]. Graefes Arch Clin Exp Ophthalmol, 2021, 259(4): 929－940.
|
| [17] |
Xiao YT, Xie HT, Liu X, et al. Subconjunctival injection of transdifferentiated oral mucosal epithelial cells for limbal stem cell deficiency in rats[J]. J Histochem Cytochem, 2021, 69(3): 177－190.
|
| [18] |
Galindo S, de－la－Mata A, López－Paniagua M, et al. Subconjunctival injection of mesenchymal stem cells for corneal failure due to limbal stem cell deficiency: state of the art[J]. Stem Cell Res Ther, 2021, 12(1): 60.
|
| [19] |
Joiner D, Steinberg Y, Kang JJ. Umbilical cord graft for refractory neurotrophic keratopathy[J]. Cornea, 2023, 2(10): 1263－1267.
|
| [20] |
苏岱，张嘉莹，李瑾. 角膜知觉重建治疗神经营养性角膜病变的研究进展[J]. 中华眼科杂志，2023，59(4)：313－320.
|
| [21] |
徐睿，李双双，韩园，等．角膜痛机制的研究进展[J].复旦学报(医学版)，2021，48(4)：541－544.
|
| [22] |
Roumeau S, Dutheil F, Sapin V, et al. Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta－analysis[J]. Graefes Arch Clin Exp Ophthalmol, 2022, 260(8): 2623－2637.
|
| [23] |
Deeks ED, Lamb YN. Cenegermin: A review in neurotrophic keratitis[J]. Drugs. 2020, 80(5): 489－494.
|
| [24] |
Yavuz－Saricay L, Bayraktutar BN, Lilley J, et al. Efficacy of recombinant human nerve growth factor in stage 1 neurotrophic keratopathy[J]. Ophthalmology, 2022, 129(12): 1448－1450.
|
| [25] |
Trinh T, Mimouni M, Santaella G, et al. Surgical management of the ocular surface in neurotrophic keratopathy: amniotic membrane, conjunctival grafts, lid surgery, and neurotization[J]. Eye Contact Lens, 2021, 47(3): 149－153.
|
| [26] |
Zhou TE, Robert MC. Comparing prokera with amniotic membrane transplantation: indications, Outcomes, and Costs[J]. Cornea, 2022, 41(7): 840－844.
|
| [27] |
Liu CY, Arteaga AC, Fung SE, et al. Corneal neurotization for neurotrophic keratopathy: Review of surgical techniques and outcomes[J]. Ocul Surf, 2021, 20: 163－172.
|
| [28] |
邵毅，胡瑾瑜，应平. 干眼炎症诊疗规范：2023欧洲专家共识解读[J].眼科新进展，2024, 44(2)：85－88.
|
| [29] |
林琳，冯云，傅瑶，等. 眼表微环境与泪膜稳态对视觉质量影响的新认识[J]. 中华眼视光学与视觉科学杂志，2022，24(12)：881－887.
|
| [30] |
Kumar NR, Praveen M, Narasimhan R, et al. Tear biomarkers in dry eye disease: Progress in the last decade[J]. Indian J Ophthalmol, 2023, 71(4): 1190－1202.
|
| [31] |
Borgia A, Raimondi R, Fossati G, et al. Device－based therapies as a boost of conventional treatment in dry eye disease[J]. Expert Rev Ophthalmol, 2022, 17: 387－393.
|
| [32] |
Vazirani J, Sridhar U, Gokhale N, et al. Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines[J]. Indian J Ophthalmol, 2023, 71(4): 1357－1363.
|
| [33] |
Watson SL, Secker GA, Daniels JT. The effect of therapeutic human serum drops on corneal stromal wound－healing activity[J]. Curr Eye Res, 2008, 33(8): 641－52.
|
| [34] |
van－der－Meer PF, Verbakel SK, Honohan Á，et al. Allogeneic and autologous serum eye drops: a pilot double－blind randomized crossover trial[J]. Acta Ophthalmol, 2021, 99(8): 837－842.
|
| [35] |
Maharajan N, Cho GW, Choi JH, et al. Regenerative therapy using umbilical cord serum[J]. In Vivo, 2021, 35(2): 699－705.
|
| [36] |
Coco G, Piccotti G, Romano V, et al. Cenegermin for the treatment of dry eye disease[J]. Drugs Today (Barc), 2023, 59(3): 113－123.
|
| [37] |
王宇珊，郑晓汾，于花，等．翼状胬肉患者术中角膜、结膜缺损面积与其术后干眼相关性的临床研究[J/OL].中华眼科医学杂志(电子版)，2023，13(6)：344－349.
|
| [38] |
Kasetsuwan N, Bhattarakosol P, Reinprayoon U, et al. Prevalence of human papillomavirus genotypes in pterygia from thai individuals [J]. Ophthalmic Epidemiol, 2022, 29(1): 85－90.
|
| [39] |
Ghiasian L, Samavat B, Hadi Y, et al. Recurrent pterygium: a review[J]. J Curr Ophthalmol, 2022, 33(4): 367－378.
|
| [40] |
Sabater－Cruz N, Dotti－Boada M, Rios J, et al. Postoperative treatment compliance rate and complications with two different protocols after pterygium excision and conjunctival autografting[J]. Eur J Ophthalmol, 2021, 31(3): 932－937.
|
| [41] |
Adriano L, Persona ELS, Persona IGS, et al. Correlation between the presumed pterygium with dry eye and with systemic and ocular risk factors[J]. Arq Bras Oftalmol, 2021, 85(2): 136－143.
|
| [42] |
Ting DSJ, Liu YC, Lee YF, et al. Cosmetic outcome of femtosecond laser－assisted pterygium surgery[J]. Eye Vis (Lond), 2021, 8(1): 7.
|
| [43] |
Alsarhani W, Alshahrani S, Showail M, et al. Characteristics and recurrence of pterygium in Saudi Arabia: a single center study with a long follow－up[J]. BMC Ophthalmol, 2021, 21(1): 207.
|
| [44] |
Crespo MA, Rapuano CJ, Syed ZA. Applications of mitomycin c in cornea and external disease[J]. Turk J Ophthalmol, 2023, 53(3): 175－182.
|
| [45] |
Lee BWH, Sidhu AS, Francis IC, et al. 5－Fluorouracil in primary, impending recurrent and recurrent pterygium: Systematic review of the efficacy and safety of a surgical adjuvant and intralesional antimetabolite[J]. Ocul Surf, 2022, 26: 128－141.
|
| [46] |
Baheran SS, Alany RG, Schwikkard S, et al. Pharmacological treatment strategies of pterygium: Drugs, biologics, and novel natural products[J]. Drug Discov Today, 2023, 28(1): 103416.
|
| [47] |
Posarelli M, Romano D, Tucci D, et al. Ocular－surface regeneration therapies for eye disorders: the state of the art[J]. BioTech (Basel), 2023, 12(2): 48.
|
| [48] |
Palewski M, Budnik A, Konopińska J. Evaluating the efficacy and safety of different pterygium surgeries: a review of the literature[J]. J Environ Res Public Health, 2022, 19(18): 11357.
|
| [49] |
Karam M, Alsaif A, Aldubaikhi A, et al. The use of fibrin glue in pterygium surgery with amniotic membrane transplantation: Systematic review and meta－analysis[J]. Saudi J Ophthalmol, 2023, 37(2): 83－89.
|
| [50] |
Mai W, Chen M, Huang M, et al. Targeting platelet－derived growth factor receptor β inhibits the proliferation and motility of human pterygial fibroblasts[J]. Expert Opin Ther Targets, 2019, 23(9): 805－817.
|